Keywords: abbott, cuts, hiv/aids, drug, prices, further, laboratories
Abbott cuts HIV/AIDS drug prices further
Article | 24 June 2002
Abbott Laboratories has announced further price cuts to itsantiretroviral drugs Kaletra (lopinavir/ritonavir) and Norvir (ritonavir), under the Abbott Access ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
